Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,717 INR | +0.37% | +0.33% | -10.79% |
07/05 | Gland Pharma Gets US FDA's Approval for Generic ALS Drug | MT |
07/05 | Gland Pharma Gets US FDA's Approval for Generic Stem Cell Mobilizer Injection | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.79% | 3.38B | |
+32.95% | 700B | |
+26.51% | 569B | |
-4.97% | 358B | |
+18.83% | 330B | |
+3.54% | 287B | |
+15.70% | 236B | |
+6.68% | 202B | |
-9.08% | 197B | |
+6.70% | 161B |
- Stock Market
- Equities
- GLAND Stock
- News Gland Pharma Limited
- Gland Pharma Gets Establishment Inspection Report from US FDA for Pashamylaram Unit